Related Experiment Video
Updated: Sep 7, 2025

11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
3.9K
Myopic Foveoschisis Completely Resolves within 12 Months after Vitrectomy
William Beaumont1, Aude Couturier1, Alain Gaudric1
1Université de Paris, Ophthalmology Department, AP-HP, Hôpital Lariboisière, Paris, France.
Ophthalmology. Retina
|June 16, 2022
Summary
Vitrectomy effectively resolves myopic foveoschisis (MFS) in most patients within a year. Decreased central foveal thickness and inner retinoschisis resolution are early indicators of successful surgical outcomes.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Medical Imaging
Background:
- Myopic foveoschisis (MFS) is a complex condition affecting the macula.
- Vitrectomy is a surgical option for MFS, but the sequence of anatomical changes post-surgery requires detailed assessment.
Purpose of the Study:
- To evaluate the chronological sequence of anatomical resolution of different MFS features after pars plana vitrectomy.
- To identify potential early biomarkers for surgical success in MFS patients.
Main Methods:
- Retrospective analysis of 39 eyes from 36 patients undergoing vitrectomy for MFS.
- Assessment of central foveal thickness (CFT), inner retinoschisis (IRS), outer retinoschisis (ORS), and foveal detachment (FD) pre- and post-operatively.
- Tracking the time to resolution of each morphological feature and overall anatomical success.
Main Results:
- Anatomical success was achieved in 82% of cases, with over 80% success within the first year.
- Inner retinoschisis resolved in a median of 1 month, foveal outer retinoschisis in 3 months, and foveal detachment in 6 months.
- Central foveal thickness significantly decreased in 79% of cases by 3 months, and best-corrected visual acuity improved.
Conclusions:
- Myopic foveoschisis demonstrates significant anatomical resolution within the first year following vitrectomy.
- Early reduction in CFT and resolution of IRS serve as valuable early indicators of successful surgical outcomes for MFS.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
553
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
553
Angle Closure Glaucoma: Treatment
660
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
660

